Hot Topics in Pharmacy: ASHP Advantage: Access Granted: Unlocking the Benefits of COVID-19 Antiviral Therapies

Hot Topics in Pharmacy: ASHP Advantage: Access Granted: Unlocking the Benefits of COVID-19 Antiviral Therapies

April 22, 2026 · 18 min · Episode 1502

About this episode

The episode discusses the role of COVID-19 antiviral therapies in improving patient outcomes and the pharmacist's role in facilitating access to these treatments.

COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low. Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes. The information presented during the podcast reflects solely the opinions of…

Topics covered

Keywords

Mentioned in this episode

Organizations: American Society of Health-System Pharmacists©

Products: COVID-19 antiviral medications

Places: United States

More episodes of ASHPOfficial

Explore listener stats, chart rankings, contacts and more on the ASHPOfficial podcast page.